Medicinal Compositions and Method for the Preparation Thereof
    1.
    发明申请
    Medicinal Compositions and Method for the Preparation Thereof 失效
    药用组合物及其制备方法

    公开(公告)号:US20080267885A1

    公开(公告)日:2008-10-30

    申请号:US10596836

    申请日:2004-12-10

    IPC分类号: A61K47/48 A61K9/12

    摘要: Methods for the manufacture of medicinal compositions are described. A method for the manufacture of a medicinal composition according to the invention comprises: (a) Providing a biocompatible polymer of the general formula —[O—R1—C(O)]n— wherein: “R1” is a linear, branched, or cyclic organic group, “n” is at least three, (b) Acylating the biocompatible polymer to provide an acylated biocompatible polymer and a mixed anhydride; (c) Reacting the mixed anhydride with a nucleophile to provide an acylated biocompatible polymer with a terminal carboxylic acid derivative capable of being chemically converted to an acid in the absence of water, (d) Converting the terminal carboxylic acid derivative to an acylated biocompatible polymer with a terminal carboxylic acid; and (e) Combining the acylated biocompatible polymer with a drug to provide the medicinal composition.

    摘要翻译: 描述了药物组合物的制造方法。 制备根据本发明的药物组合物的方法包括:(a)提供具有通式的生物相容性聚合物 - [OR 1 -C 2 -C(O)] n 其中:“R 1”是直链,支链或环状有机基团,“n”为至少三个,(b)酰化生物相容性聚合物以提供酰化生物相容性聚合物和混合 酐; (c)用亲核试剂反应混合酸酐以提供酰化的生物相容性聚合物,其具有能够在不存在水的情况下化学转化为酸的末端羧酸衍生物; (d)将末端羧酸衍生物与末端羧酸转化成酰化生物相容性聚合物; 和(e)将酰化的生物相容性聚合物与药物组合以提供药物组合物。

    LEAD INCLUDING COMPOSITE DEVICE FOR ELUTING A STEROID AND AN ANTIMICROBIAL
    3.
    发明申请
    LEAD INCLUDING COMPOSITE DEVICE FOR ELUTING A STEROID AND AN ANTIMICROBIAL 审中-公开
    引导包括用于施用杀菌剂和抗微生物剂的复合装置

    公开(公告)号:US20110125241A1

    公开(公告)日:2011-05-26

    申请号:US12625385

    申请日:2009-11-24

    IPC分类号: A61N1/05 A61M37/00

    CPC分类号: A61N1/0568 A61N1/0575

    摘要: A lead may include a lead body including a proximal end and a distal end, an electrode proximate to the distal end of the lead body, and a monolithic controlled release device located proximate to the electrode. According to this aspect of the disclosure, the monolithic controlled release device includes a polymer, a steroid mixed in the polymer, and an antimicrobial mixed in the polymer.

    摘要翻译: 引线可以包括引线主体,其包括近端和远端,靠近引线主体的远端的电极以及位于电极附近的单片控制释放装置。 根据本公开的该方面,单片控释装置包括聚合物,混合在聚合物中的类固醇和在聚合物中混合的抗微生物剂。

    Medicinal compositions and method for the preparation thereof
    5.
    发明授权
    Medicinal compositions and method for the preparation thereof 失效
    药物组合物及其制备方法

    公开(公告)号:US07597897B2

    公开(公告)日:2009-10-06

    申请号:US10596836

    申请日:2004-12-10

    摘要: Methods for the manufacture of medicinal compositions are described. A method for the manufacture of a medicinal composition according to the invention comprises: (a) Providing a biocompatible polymer of the general formula —[O—R1—C(O)]n— wherein: “R1” is a linear, branched, or cyclic organic group, “n” is at least three, (b) Acylating the biocompatible polymer to provide an acylated biocompatible polymer and a mixed anhydride; (c) Reacting the mixed anhydride with a nucleophile to provide an acylated biocompatible polymer with a terminal carboxylic acid derivative capable of being chemically converted to an acid in the absence of water, (d) Converting the terminal carboxylic acid derivative to an acylated biocompatible polymer with a terminal carboxylic acid; and (e) Combining the acylated biocompatible polymer with a drug to provide the medicinal composition.

    摘要翻译: 描述了药物组合物的制造方法。 制备根据本发明的药用组合物的方法包括:(a)提供通式为[O-R 1 -C(O)] n - 的生物相容性聚合物,其中:“R 1”为直链,支链, 或环状有机基团,“n”为至少三个,(b)酰化生物相容性聚合物以提供酰化生物相容性聚合物和混合酸酐; (c)用亲核试剂反应混合酸酐以提供酰化的生物相容性聚合物,其具有能够在不存在水的情况下化学转化为酸的末端羧酸衍生物; (d)将末端羧酸衍生物与末端羧酸转化成酰化生物相容性聚合物; 和(e)将酰化的生物相容性聚合物与药物组合以提供药物组合物。